Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione del Piemonte per l'Oncologia
Eastern Cooperative Oncology Group
A2 Biotherapeutics Inc.
Arvinas Inc.
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
University of Nebraska
EXoPERT
Colorado State University
Orano Med LLC
Imperial College London
Institut du Cancer de Montpellier - Val d'Aurelle
Massachusetts General Hospital
University of Pittsburgh
Washington University School of Medicine
Travera Inc
GONGCHU Biotechnology Co., Ltd
ModeX Therapeutics, An OPKO Health Company
Stanford University
Hospital Universitario de Fuenlabrada
Avera McKennan Hospital & University Health Center
Centro di Riferimento Oncologico - Aviano
Glasgow Royal Infirmary
Odense University Hospital